Calidi Biotherapeutics elects Alan Stewart as director, ratifies auditor at annual meeting

Calidi Biotherapeutics, Inc.

Quorum of 57.57% (4,641,839 shares) present at Sep 20, 2024 annual meeting.
Alan Stewart elected Class I director with 2,055,631 votes for; 2,586,208 abstentions, no against.
George Ng did not stand for re-election; Board reduced from 6 to 5 members, no vacancy.
Ratification of Marcum LLP as auditor passed with 4,547,883 for, 36,790 against, 57,166 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.